Atlas Trials

Vaccination of Ex-acute COVID-19 Patients With Fibrosing Lung Syndrome at Discharge

Clinical trial NCT04537130 · UNKNOWN

Trial details

NCT number
NCT04537130
Sponsor
Instituto Oncológico Dr Rosell
Status
UNKNOWN
Phase
Phase 1
Study type
INTERVENTIONAL
Pulmonary FibrosisCovid19
Start date
2020-12-01
Primary completion
2021-06-01
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.